Intellectual Property Alert: Federal Circuit Hears Arguments in Association for Molecular Pathology v. USPTO


On April 4, 2011, before a well-filled courtroom, the Court of Appeals for the Federal Circuit heard arguments in the Myriad case.1 The case could potentially reach the issue of subject matter patentability of claims to isolated DNA under Section 101 of the patent statute.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Intellectual Property Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Banner & Witcoff, Ltd. | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »